GeoVax Labs Inc. | |
Stock Exchange | Other OTC |
EPS |
$6.91 |
Market Cap |
$384.3 K |
Shares Outstanding |
610 K |
Public Float |
251.91 M |
Address |
1900 Lake Park Drive Smyrna Georgia 30080 United States |
Employees | - |
Website | http://www.geovax.com |
Updated | 07/08/2019 |
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. |